SANGAMO THERAPEUTICS, INC. (SGMOQ) Net income 2016–2025
SANGAMO THERAPEUTICS, INC. (SGMOQ) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$122.9MFY2025 · since FY2016: -$71.7M → -$122.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$122.9M | -25.5% |
| FY2024 | -$97.9M | +62.0% |
| FY2023 | -$257.8M | -34.1% |
| FY2022 | -$192.3M | -7.8% |
| FY2021 | -$178.3M | -47.3% |
| FY2020 | -$121.0M | -27.1% |
| FY2019 | -$95.2M | -39.3% |
| FY2018 | -$68.3M | -25.2% |
| FY2017 | -$54.6M | +23.8% |
| FY2016 | -$71.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SGMOQ financial trends
SGMOQ RevenueSGMOQ Net marginSGMOQ Gross profitSGMOQ Gross marginSGMOQ Operating incomeSGMOQ Operating marginSGMOQ Operating cash flowSGMOQ Free cash flowSGMOQ Capital expendituresSGMOQ Return on equitySGMOQ Stock buybacksSGMOQ Dividends paidSGMOQ Total assetsSGMOQ Total liabilitiesSGMOQ Shareholders’ equitySGMOQ overview →